Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 20, 2018
Pharmacy Choice - News - Front Page Healthcare News - July 20, 2018

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

12/31/17 - Drug for spinal muscular atrophy prompts ethical dilemmas, Stanford bioethicists say
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA When the Food and Drug Administration approved the first drug for people with spinal muscular atrophy a year ago, clinicians finally had hope for improving the lives of patients with the rare debilitating muscular disease. They teamed up with colleagues at several other instit
12/31/17 - Medicaid expansion popular among Americans connected to program
By a News Reporter-Staff News Editor at VerticalNews Health& Science A concerted effort by Republicans in Congress to repeal and replace the Affordable Care Act hit a surprising road block earlier this year: strong pushback against cuts to Medicaid. According to new findings from researchers at the University of Chicago, Medicaid is now seen as a
12/31/17 - NAB approves corruption probe against NWA Agency Surgeon, FDA, FATA Secretariat officers
PESHAWAR: The National Accountability Bureau has approved inquiry against Agency Surgeon of North Waziristan, FATA Secretariat and FATA Development Authority officers over corruption and misuse of powers. The Executive Board of the NAB Khyber Pakhtunkhwa met in Peshawar on Thursday with the director general in the chair. Inquiry was also approved..
12/31/17 - That feeling in your bones
Unjustly so, according to new research from Harvard Medical School. The newly published analysis led by Anupam Jena of Harvard Medical School's Department of Health Care Policy, used a "big data" approach, linking insurance claims from millions of doctor's visits with daily rainfall totals from thousands of National Oceanic and Atmospheric Administ
12/31/16 - Toxic Beauty: Bed, bath and way beyond
Heavy Metal and makeup have more in common than you might know. Lipsticks, mascara, sunblock, and deodorant are just a few of the toxic products that contain levels of heavy metals and other substances that are unregulated by the FDA. Unlike drug companies, cosmetics companies may use almost any ingredients they choose, with few exceptions.
12/30/17 - 233,000 sign up for Affordable Care Act insurance in Ohio
The data provided Thursday by the Centers for Medicare and Medicaid Services represent enrollment only in the 39 states that use the federal health-care marketplace HealthCare.gov to sign up for coverage. The remaining states and the District of Columbia run their own health exchanges, many of which have extended deadlines. This is fabulou
12/30/17 - Aga Khan University Hospital Becomes First In E. A. to Acquire Ultra-Modern PET CT Scanner [Tehran Times (Iran)]
Aga Khan University Hospital in Nairobi has acquired an ultra-modern Positron Emission Tomography CT scanner and Cyclotron, a first in East and Central Africa. Aga Khan University Hospital continues to be at the front of the fight against non-communicable diseases through evidence-based medicine backed by res-earch, a team-based approach and modern
12/30/17 - Aptose`s pan-FLT3/pan-BTK inhibitor, CG806 to treat AML receives US FDA orphan drug status [T-break Tech (Middle East)]
Aptose Biosciences, a clinical-stage biotechnology company, has announced that the US Food and Drug Administration has granted orphan drug designation to CG806, a highly potent pan-FLT3/pan-BTK inhibitor, for the treatment of patients with acute myeloid leukemia. We are pleased that the FDA has recognized the unique potential of CG806 to address AM
12/30/17 - Atara Biotherapeutics Announces FDA Clearance to Initiate Two Phase 3 Clinical Studies to Evaluate Tabelecleucel in Patients with Rituximab-Refractory Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disorder (EBV+PTLD) [Tehran Times
Atara Biotherapeutics, Inc., a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today announced that it received clearance from the U.S. Food and Drug Administration to initiate two Phase 3 clinical studies with tabelecleucel in patients with rituximab-refractory
12/30/17 - Attention Biotech Investors: Brace For These January PDUFA Events
The biotech sector rebounded in 2017, with the iShares NASDAQ Biotechnology Index rallying more than 21 percent. This follows an underwhelming performance in 2016, when the IBB lost 21.6 percent. Synergy Seeks Approval for Expanded Use Of Its Constipation Drug Company: Synergy Pharmaceuticals Inc Type of Application: Supplemental New Drug Applicati
12/30/17 - Avadel Pharmaceuticals Issues 2018 Corporate Outlook [Tehran Times (Iran)]
-Avadel Pharmaceuticals plc, Avadel or the Company, today announced its 2018 corporate objectives and financial expectations, including the commercial launch of Noctiva and the anticipated filing of a New Drug Application for both FT218, a once-nightly formulation of sodium oxybate using Micropump, and its fourth Unapproved Marketed Drug product, A
12/30/17 - Boryung Vigencell to enter phase 2 studies on T-cell immunotherapy [Sport360]
Boryung Vigencell, an affiliate of Korean drug maker Boryung Pharmaceutical, said on Dec. 28 that the countrys regulator has approved its Investigational New Drug application to initiate phase 2 clinical trials of its T-cell immunotherapy. The company was able to create tumor-specific cytotoxic T-cells which play a vital role in the immune respon
12/30/17 - CStone`s anti-CTLA-4 antibody CS1002 filed for clinical trial approval in Australia [Syrian Arab News Agency]
CStone Pharmaceuticals Co., Ltd, today announced that an investigational new drug filing has been submitted to Human Research Ethics Committees of the Ashford Cancer Center in Australia for CS1002, an independently-developed investigational cytotoxic T-lymphocyte-associated protein-4 inhibitor. Frank Jiang, Chief Executive Officer of CStone...
12/30/17 - Delivery Of A New Digitization System For Mammography And Conventional Images For The Needs Of The Diagnostic Department In Kots Bourgas Eood. [TendersInfo (India)]
Contract notice: Delivery of a new digitization system for mammography and conventional images for the needs of the diagnostic department in "kots bourgas" eood. Supply, Installation, Personnel training and commissioning, Including warranty service of a new digitization system for mammography and conventional imaging, For the needs of the diagnosti
12/30/17 - DRAP completing free process of digital listing of all registered drugs
Drug Regulatory Authority said Division of Pharmaceutical Evaluation and Registration, DRAP completing free the process of digital listing of all registered drugs and in this aspect a provisional database has been uploaded on the official website of DRAP. The Authority has initiated the process early in this year for computerization of decades old.
12/30/17 - DRAP starts digital listing of registered drugs - Press Note issued by Press Information Department
Following is the text of press note issued by Press Information Department. Drug Regulatory Authority said Division of Pharmaceutical Evaluation and Registration, DRAP completing free the process of digital listing of all registered drugs and in this aspect a provisional database has been uploaded on the official website of DRAP. The Authority has.
12/30/17 - Edge`s EG-1962 Phase 3 NEWTON 2 Study Continues as Planned Following Completion of Futility Analysis [Times of Zambia]
-Edge Therapeutics, Inc., a clinical-stage biotechnology company developing novel hospital-based therapies for the management of acute, life-threatening conditions, today announced that an independent Data Monitoring Committee recommended that the Phase 3 NEWTON 2 study of EG-1962 continue as planned based on the completion of a pre-planned futilit
12/30/17 - ENDOLOGIX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Endologix, Inc. - ELGX
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick& Foti, LLC, announces that KSF has commenced an investigation into Endologix, Inc.. On August 2, 2016, the Company issued a press release in which CEO John McDermott touted the performance of one of its devices, the Nellix EndoVascular Aneurysm
12/30/17 - FDA Clears Clinical Studies To Evaluate Tabelecleucel In Epstein-Barr Virus Therapy [Arab Times (Kuwait)]
Atara Biotherapeutics announces FDA clearance to initiate two Phase 3 clinical studies to evaluate tabelecleucel in patients with rituximab-refractory Epstein-Barr virus associated post-transplant lymphoproliferative disorder. Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company developing novel treatments for...
12/30/17 - FDA Permits Marketing of Device to Treat Diabetic Foot Ulcers [Sudan Tribune]
"Diabetes is the leading cause of lower limb amputations," said Binita Ashar, M.D., director of the division of surgical devices in FDA`s Center for Devices and Radiological Health. "The FDA is dedicated to making technologies available that can help improve the quality of life for those with chronic diseases. An estimated 30.3 million people in t
12/30/17 - Immunoassay Systems Market to Remain Lucrative During 2017-2025: Continuous increase in R&D expenditures and increasing research grants and government funding to research laboratories would further increase the demand for immunoassay systems.
Albany, NY 12/29/2017 Immunoassay has become essential laboratory technique that can be used to measure concentration of different analytes. Some of the established brands in global immunoassay systems include ADVIA, UniCel DxI, IDS-iSYS, LUMINEX, Cobas Analyzer etc. among others. The global market for immunoassay systems is expected to be dr
12/30/17 - Jubilant Life Sciences receives sNDA approval for new indications from USFDA for DRAXIMAGE DTPA [Syrian Arab News Agency]
Jubilant Life Sciences Ltd, an integrated global Pharmaceutical and Life Sciences Company, has announced that Jubilant Pharma Limited, a material wholly owned subsidiary of the Company, through one of its wholly owned subsidiaries, has received a Supplemental New Drug Application approval from USFDA for DRAXIMAGE DTPA powder for solution.
12/30/17 - La Jolla Pharma Gets FDA Approval for Blood Pressure Drug [Sudan Tribune]
Last week, La Jolla Pharmaceutical Company received FDA approval for their low blood pressure injectible Giapreza. The intravenous injectible is used to raise blood pressure in adults with certain symptoms like sepsis, shock, and hypertension, but can also cause dangerous blood clots. In a 321 patient clinical trial Giapreza raised blood pressure a
12/30/17 - Lawmakers start their engines
Taxes and health care insurance reform are expected to be the big issues when the Idaho legislative session begins Monday, Jan. 8. Mary Souza, R- Coeur d'Alene. Idaho lawmakers will be dealing with changes to federal tax laws and President Donald Trump's removal of the individual mandate requirement as part of the Affordable Care Act, otherwise kno
12/30/17 - Mallinckrodt Completes Acquisition of Ocera Therapeutics and OCR-002, Its Proprietary Therapy in Development for Treatment of Hepatic Encephalopathy
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Mallinckrodt plc, a leading global specialty pharmaceutical company, announced it has closed the acquisition of Ocera Therapeutics, a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for orphan and other serious l
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415